Clin2
NCT07343726Likely a fitNot yet recruiting

How obesity affects IBD treatment response

Inflammatory Bowel Disease (IBD)

Part of Digestive system clinical trials.

This study looks at how being overweight affects how well treatment works for people with inflammatory bowel disease (IBD), like Crohn's or ulcerative colitis. It may help doctors understand if obesity changes outcomes or the need for stronger medications.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years old or older
  • You have been diagnosed with inflammatory bowel disease (IBD)
  • You are currently getting standard treatment for IBD, which may include biologic medications
  • You do not have other causes of colon inflammation, such as infection or lack of blood flow
  • You are not pregnant
  • Your medical records are complete and available for review

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07775794Recruiting
Moderate exercise for quiet bowel disease

This study looks at whether a moderate exercise program can help people with inflammatory bowel disease (IBD) feel better and manage their condition. It aims to see if exercise improves overall health without worsening symptoms.

Bangkok Noi, Bangkok
NCT06939569Recruiting
Studying fatty liver disease in people with inflammatory bowel disease

This study looks at how common non-alcoholic fatty liver disease is in people with inflammatory bowel disease (Crohn's or colitis). Researchers want to learn more about the link between the two conditions.

Shanghai
NCT07162701Recruiting
Body composition study for inflammatory bowel disease

This study looks at body composition (fat and muscle) in people with Crohn's disease or ulcerative colitis. It tests if a new way to monitor body changes can help guide treatment with biologic or JAK inhibitor medicines.

Barcelona
NCT07495800Not yet recruiting
Weight changes in IBD patients on infliximab and cost effects

This study looks at how weight and body mass index (BMI) change in people with inflammatory bowel disease (IBD) who are taking infliximab, and whether these changes affect treatment costs.

NCT06937099Recruiting· Phase 3
Testing two drugs for Crohn's with weight issues

This trial tests two study drugs, mirikizumab and tirzepatide, in people with moderate to severe Crohn's disease who also have overweight or obesity. The goal is to see if these treatments can help control Crohn's symptoms and inflammation.

Dothan, Alabama
NCT06550310Recruiting
Nutrition and IBD treatment outcomes

This study looks at how nutrition affects people with IBD who are starting a new treatment or having surgery. Researchers want to find out if diet or body changes influence how well you recover.

London

Hear when a new Inflammatory Bowel Disease (IBD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.